BluePath Capital Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Buy
+1,571
New +$229K 0.13% 121
2025
Q2
Sell
-4,995
Closed -$851K 92
2025
Q1
$851K Sell
4,995
-2,385
-32% -$399K 0.89% 25
2024
Q4
$1.17M Buy
7,380
+1,242
+20% +$212K 0.63% 40
2024
Q3
$1.06M Buy
6,138
+939
+18% +$159K 0.66% 29
2024
Q2
$857K Buy
5,199
+1,111
+27% +$182K 0.6% 36
2024
Q1
$663K Buy
4,088
+2,596
+174% +$407K 0.5% 38
2023
Q4
$224K Buy
1,492
+14
+0.9% +$2.07K 0.19% 98
2023
Q3
$216K Buy
+1,478
New +$226K 0.2% 94

Other funds holding PG

BluePath Capital Management's PG Position: Q2 2026 in Review

BluePath Capital Management opened a new position in Procter & Gamble (PG) in Q2 2026: 1,571 shares worth $230K. The stake represents 0.13% of the portfolio and ranks #121 among its holdings. This is a return to the name: BluePath Capital Management previously reported a position in PG as recently as Q1 2025.

BluePath Capital Management first reported a position in PG in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.17M in Q4 2024. 1,371 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • BluePath Capital Management held 1,571 shares of Procter & Gamble worth $230K as of Q2 2026.
  • Procter & Gamble was a new BluePath Capital Management position in Q2 2026.
  • Procter & Gamble made up 0.13% of BluePath Capital Management's portfolio in Q2 2026, its #121 holding.
  • BluePath Capital Management first reported a position in Procter & Gamble in Q3 2023 and has held it in 8 quarters since.
  • BluePath Capital Management's Procter & Gamble position peaked at $1.17M in Q4 2024.
  • 1,371 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.